OIA
FLGT icon

Optimum Investment Advisors’s Fulgent Genetics FLGT Stock Holding History

Optimum Investment Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$6K – 855
2022
Q1 		$6K Hold
100
– – ﹤0.01% 707
2021
Q4 		$10K Hold
100
– – ﹤0.01% 677
2021
Q3 		$9K Hold
100
– – ﹤0.01% 692
2021
Q2 		$9K Hold
100
– – ﹤0.01% 755
2021
Q1 		$10K Sell
100
-200
-67% -$20.6K ﹤0.01% 764
2020
Q4 		$16K Buy
+300
New +$12.5K ﹤0.01% 658

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Optimum Investment Advisors's FLGT Position: Q2 2022 in Review

Optimum Investment Advisors sold out of Fulgent Genetics (FLGT) in Q2 2022, closing a stake of 100 shares — an estimated $6K sold.

Optimum Investment Advisors first reported a position in FLGT in Q4 2020 and held it in 6 quarters. The position peaked at $16K in Q4 2020. 262 funds tracked by Wall St. Rank hold FLGT as of Q2 2022.

  • Optimum Investment Advisors reported no remaining Fulgent Genetics position as of Q2 2022 after selling out during the quarter.
  • Optimum Investment Advisors sold 100 Fulgent Genetics shares in Q2 2022, an estimated $6K.
  • Optimum Investment Advisors first reported a position in Fulgent Genetics in Q4 2020 and held it in 6 quarters.
  • Optimum Investment Advisors's Fulgent Genetics position peaked at $16K in Q4 2020.
  • 262 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2022.

Based on Optimum Investment Advisors's 13F filing for Q2 2022, filed 12 Jul 2022.